Lv63
1650 积分 2022-05-24 加入
Asundexian versus Apixaban in Patients with Atrial Fibrillation
5小时前
已完结
Asundexian versus Apixaban in Patients with Atrial Fibrillation
6小时前
已完结
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism
22小时前
已完结
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
1天前
已完结
中国心房颤动管理指南（2025）
2天前
已完结
87MO Capivasertib (C) + paclitaxel (P) as first-line treatment of metastatic triple-negative breast cancer: The CAPItello-290 phase III trial extended China cohort
8天前
已关闭
An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044)
8天前
已完结
[Guidelines on clinical practice of molecular tests in breast cancer in China (2025 edition)]
9天前
已完结
[Guidelines on tests of PIK3CA mutation in breast cancer in China (2025 version)]
9天前
已完结
B- and Plasma Cell Subsets in Autoimmune Diseases: Translational Perspectives
18天前
已完结
皖公网安备34019202002308
